Ray Co., Ltd. (228670.KQ)

KRW 6250.0

(-2.5%)

Net Debt Summary of Ray Co., Ltd.

Ray Co., Ltd.'s latest annual net debt in 2023 was 67.09 Billion KRW , up 3.09% from previous year.
Ray Co., Ltd.'s latest quarterly net debt in 2024 Q2 was 85.12 Billion KRW , up 24.45% from previous quarter.
Ray Co., Ltd. reported annual net debt of 65.08 Billion KRW in 2022, up 141.22% from previous year.
Ray Co., Ltd. reported annual net debt of 26.98 Billion KRW in 2021, up 827.85% from previous year.
Ray Co., Ltd. reported quarterly net debt of 68.39 Billion KRW for 2024 Q1, up 1.94% from previous quarter.
Ray Co., Ltd. reported quarterly net debt of 65.58 Billion KRW for 2023 Q3, up 18.02% from previous quarter.

Annual Net Debt Chart of Ray Co., Ltd. (2023 - 2017)

Historical Annual Net Debt of Ray Co., Ltd. (2023 - 2017)

Year	Net Debt	Net Debt Growth
2023	67.09 Billion KRW	3.09%
2022	65.08 Billion KRW	141.22%
2021	26.98 Billion KRW	827.85%
2020	-3.7 Billion KRW	48.57%
2019	-7.2 Billion KRW	18.19%
2018	-8.81 Billion KRW	-1067.7%
2017	910.42 Million KRW	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	85.12 Billion KRW	24.45%
2024 Q1	68.39 Billion KRW	1.94%
2023 Q3	65.58 Billion KRW	18.02%
2023 Q4	67.09 Billion KRW	2.3%
2023 FY	67.09 Billion KRW	3.09%
2023 Q2	55.57 Billion KRW	-8.02%
2023 Q1	60.41 Billion KRW	-7.17%
2022 Q3	59.31 Billion KRW	804.32%
2022 Q4	65.08 Billion KRW	9.73%
2022 Q2	6.55 Billion KRW	-37.5%
2022 Q1	10.49 Billion KRW	-61.11%
2021 Q4	26.98 Billion KRW	57.96%
2021 Q3	17.08 Billion KRW	0.0%

Peer Net Debt Comparison of Ray Co., Ltd.

Name	Net Debt	Net Debt Difference
Osang Healthcare Co.,Ltd	-108.91 Billion KRW	161.601%
InBody Co.,Ltd	-16.2 Billion KRW	514.021%
Curexo Inc.	-15.03 Billion KRW	546.33%
Seegene, Inc.	-48.57 Billion KRW	238.12%
i-SENS, Inc.	98.45 Billion KRW	31.853%
Gencurix Inc.	15.02 Billion KRW	-346.548%
Sugentech Inc.	-6.95 Billion KRW	1065.19%
L&C Bio Co., Ltd	67.18 Billion KRW	0.134%